Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Inhalable liquid formulations of DNase I

Inhalable liquid formulations of DNase I

US Patent 9603906 · Granted Mar 28, 2017

Estimated economic value: $1,359,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Small shedding blocking agents2025
Bacteriophage for modulating inflammatory bowel disease2025
Methods of use for anti-ILT2 antibodies2025
Stabilized alpha-galactosidase and uses thereof2025
Stabilized alpha-galactosidase and uses thereof2025
Stabilized alpha-galactosidase and uses thereof2025
Removal of constructs from transformed cells2025
Therapeutic regimen for the treatment of Fabry using stabilized alpha-galactosid2025
Methods and compositions for decreasing soluble immune receptor CD282024
Antibodies against ILT2 and use thereof2024
Modified DNase and uses thereof2023
Modified DNase and uses thereof2023